Peri-partum cardiomyopathy is a form of heart failure affecting young mothers during later stages of pregnancy or early post-partum. Medical management should be tailored to improving the mother's health while ensuring safety of the baby.

Which of the currently available heart failure drugs are safe in pregnancy and during breast feeding? What are the outcomes of women with peripartum cardiomyopathy, who undergo LVAD implantation or heart transplantation?

In this interview, Dharini Ramu, MD, FACC and Spencer B. King III, MD, MACC, with Yuvraj Chowdhury MD, discuss Medical and Advanced Heart Failure Therapies in Peri-partum cardiomyopathy: A Cardiologist’s Perspective.

Related References:

1. Heart Transplantation for Peripartum Cardiomyopathy: Outcomes over Three Decades. Published in The Annals of Thoracic Surgery 2021
2. The upcoming trial of Bromocriptine in Peri-partum cardiomyopathy - "REBIRTH" Trial
3. A Mother's Heart: A #SheForShe Symposium on Pregnancy and Heart Failure

Clinical Topics: Heart Failure and Cardiomyopathies, Acute Heart Failure, Prevention

Keywords: ACCELLite, Heart Failure, Pregnancy

< Back to Listings